Veterinary Medicines

Avishield IBD INT, lyophilisate for oculonasal suspension/use in drinking water for chickens

Authorised
  • Infectious bursal disease virus, strain VMG 91, Live
Download as PDF

Product identification

Medicine name:
Avishield IBD INT, lyophilisate for oculonasal suspension/use in drinking water for chickens
AVISHIELD IBD INT ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΓΙΑ ΟΦΘΑΛΜΟΡΙΝΙΚΟ ΕΝΑΙΩΡΗΜΑ/ ΓΙΑ ΧΟΡΗΓΗΣΗ ΜΕ ΠΟΣΙΜΟ ΝΕΡΟ
Active substance:
  • Infectious bursal disease virus, strain VMG 91, Live
Target species:
  • Chicken
Route of administration:
  • Oculonasal use
  • Oral use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain VMG 91, Live
    5.00
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Oral lyophilisate
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken
      • All relevant tissues
        no withdrawal period
  • Oral use
    • Chicken
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • Carton box with 10 vials of 5000 doses of vaccine
  • Carton box with 10 vials of 2500 doses of vaccine
  • Carton box with 10 vials of 1000 doses of vaccine

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Genera d.d.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 8946/28-01-2019/K-0232601
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0244/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."